(Press-News.org) A study led by VA Puget Sound Health Care System researchers has shown that prazosin, a drug used to treat high blood pressure, can prevent posttraumatic headaches.
Senior study author Dr. Murray Raskind, director of the VA Northwest Mental Illness Research, Education and Clinical Center in Seattle, Washington, explained that few treatment options exist for this type of headache.
“Persistent posttraumatic headaches are the most common long-term consequence of mild traumatic brain injuries (concussions) in Veterans and active-duty service members, causing substantial distress and disability at home and work. Although these headaches usually resemble migraine headaches symptomatically, they often fail to respond to the prevention treatments useful for migraines,” said Raskind.
The FDA approved prazosin to treat hypertension in 1976. It has been widely used “off-label” to treat conditions such as PTSD-associated nightmares and enlarged prostate. An earlier study by members of the research group suggested that prazosin could reduce the frequency and severity of headaches caused by traumatic brain injury (TBI).
To test this effect, the researchers conducted a pilot study with 48 Veterans and service members with headaches caused by mild TBI, also known as a concussion. Participants took gradually increasing doses of prazosin for five weeks before receiving the maximum dose for 12 weeks. The study showed that the drug was well-tolerated, and researchers reported that morning drowsiness was the only adverse effect.
Before the trial began, study participants had an average of 18 headache days each month. By the end of the 12-week period, those taking prazosin only had headaches for an average of six days a month. Participants receiving a placebo reported some reduction in headaches, but still had headaches about 12 days a month. Significantly more participants in the prazosin group had at least 50% fewer headaches during the 12 weeks of taking a full dose of medication.
Participants taking prazosin also saw significant decreases in how much headaches impacted their quality of life. By the end of the trial, those taking prazosin reported that headaches had “some impact” on their daily ability to function, while participants given a placebo continued to report “severe impact” of headaches.
Larger clinical trials are needed to confirm the extent of these promising results, according to the researchers, but these initial findings offer a potential relief for a common ailment faced by many Veterans.
“This study is the only clinical trial of an oral medication to demonstrate efficacy for posttraumatic headache. Because prazosin is widely used across VA and the Department of Defense to treat PTSD trauma nightmares and sleep disruption, many VA and DOD prescribers are familiar with prescribing this generically available, inexpensive medication,” said Raskind. “Prazosin now offers an evidence-based approach to alleviate the suffering of Veterans and service members who have struggled for years with frequent posttraumatic headaches.”
TBI has been called the “signature injury” of the recent wars in Iraq and Afghanistan. Since 2000, more than 460,000 service members have sustained a TBI, most of which were mild TBIs. Headaches are common following a mild TBI, and they often become chronic and cause substantial disability and distress.
The study results appeared in the June 14, 2023, issue of Headache, the Journal of Head and Face Pain.
END
Blood pressure drug could prevent posttraumatic headaches
2023-06-21
ELSE PRESS RELEASES FROM THIS DATE:
Ketone supplements worsen performance in trained endurance athletes, researchers find
2023-06-21
Hamilton, ON, June 21, 2023 – Kinesiologists at McMaster University have found ketone supplements, used by some athletes hoping to cross the finish line faster, may in fact worsen performance.
The new study, published in the latest print edition of the International Journal of Sport Nutrition and Exercise Metabolism, tackles contradictory research findings related to the effectiveness of ketone supplements, which have gained popularity among athletes seeking a competitive advantage.
Some previously published studies had shown the supplements improve performance, while others have reported they had no effect or even worsened performance.
Natural ketones can ...
Exoplanet may reveal secrets about the edge of habitability
2023-06-21
ITHACA, N.Y. – How close can a rocky planet be to a star, and still sustain water and life? A recently discovered exoplanet may be key to solving that mystery.
“Super-Earth” LP 890-9c (also named SPECULOOS-2c) is providing important insights about conditions at the inner edge of a star’s habitable zone and why Earth and Venus developed so differently, according to new research led by Lisa Kaltenegger, associate professor of astronomy at Cornell University.
Her team found LP 890-9c, which orbits close to the inner ...
The art and science of living-like architecture
2023-06-21
“This technology is not alive,” says Laia Mogas-Soldevila. “It is living-like.”
The distinction is an important one for the assistant professor at the Stuart Weitzman School of Design, for reasons both scientific and artistic. With a doctorate in biomedical engineering, several degrees in architecture, and a devotion to sustainable design, Mogas-Soldevila brings biology to everyday life, creating materials for a future built halfway between nature and artifice.
The architectural technology she describes is unassuming ...
Phone communication spurs a cascading effect on social influence
2023-06-21
AUSTIN, Texas – Social influence from phone communications is significant, reaching as far as four degrees of separation from the original caller, according to a new study from researchers at The University of Texas at Austin, who developed a new framework to more precisely study the phenomenon.
The researchers created a framework that distinguishes between people behaving in similar ways because of peer influence or because they’ve sought out friends with similar behaviors and beliefs. It’s an important distinction to make for marketing and public health agencies looking to effectively ...
New findings show mitochondrial DNA fragments in blood as important biomarkers for aging and inflammation
2023-06-21
In an eight-year study of more than 600 community-dwelling older adults, Johns Hopkins Medicine researchers say they have further linked levels of cell-free DNA (DNA fragments resulting from cell death) circulating in the blood to chronic inflammation and frailty. The study is novel and expands on previous work, the investigators say, because it focused on mitochondrial DNA rather than solely genomic DNA, as previously reported in October 2022.
The new findings, published May 23 in Immunity ...
Engineers “strike gold” with innovation that recovers heavy metals from biosolids
2023-06-21
Engineers in Melbourne have developed a cost-effective and environmentally friendly way to remove heavy metals, including copper and zinc, from biosolids.
The team’s work, led by RMIT University in collaboration with South East Water and Manipal University in India, advances other methods for heavy-metal removal by recycling the acidic liquid waste that is produced during the recovery phase, instead of throwing it away.
Lead senior researcher Professor Kalpit Shah from RMIT said the heavy metals found in biosolids ...
Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens for enhanced protection
2023-06-21
A team of researchers from the Chinese Academy of Sciences, the Chinese Academy of Agricultural Sciences, and Beijing Institute of Pharmacology and Toxicology have made significant progress in developing multi-valent mRNA vaccines against monkeypox virus (MPV), the agent that can cause smallpox-like disease in humans. Their study showed the multi-valent mRNA vaccines with different combinations of monkeypox enveloped viron (EV) or mature viron (MV) surface antigens induced dynamic immune responses with a robust IgG response and correlating neutralizing activities. The ...
People who develop diabetes after pregnancy are less likely to regain control of blood sugar if they had gestational diabetes
2023-06-21
People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes during their pregnancy, especially if they were Black or Hispanic, according to a Mount Sinai study published on June 21 in the journal Diabetes Care.
The study also found that people who experienced gestational diabetes were more than 11 times as likely as those whose pregnancies did not involve gestational diabetes to develop diabetes within nine years after delivery.
The researchers, from the Icahn School of Medicine at Mount Sinai, found that the ...
Helping ‘good’ gut bacteria and clearing out the ‘bad’ — all in one treatment
2023-06-21
Probiotics can help maintain a healthy gut microbiome or restore populations of “good bacteria” after a heavy course of antibiotics. But now, they could also be used as an effective treatment strategy for certain intestinal diseases, such as Crohn’s disease. Researchers reporting in ACS Central Science have developed a microgel delivery system for probiotics that keeps “good” bacteria safe while actively clearing out “bad” ones. In mice, the system treated intestinal inflammation without side effects.
In the digestive system, there’s a delicate balance of bacterial populations. ...
FDA grants de novo clearance to Tristel ULT™ as a high-level disinfectant for ultrasound applications
2023-06-21
FAIRFIELD, NJ—Parker Laboratories Inc., a worldwide leader in ultrasound supplies and accessories, has announced the US Food and Drug Administration (FDA) has granted clearance for a unique disinfecting foam, called Tristel ULT, as a high-level disinfectant for ultrasound probes used within body cavities and for skin-surface transducers.
Tristel ULT is manufactured and distributed for US markets by Parker Laboratories under an exclusive commercial partnership with UK-based Tristel plc (AIM: TSTL). Tristel ULT is a high-level disinfectant using a proprietary ...